VolitionRX Net Income 2012-2021 | VNRX

VolitionRX net income from 2012 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
VolitionRX Annual Net Income
(Millions of US $)
2020 $-20
2019 $-16
2018 $-18
2017 $-15
2016 $-12
2015 $-10
2014 $-8
2013 $-4
2012 $-4
2011 $-3
VolitionRX Quarterly Net Income
(Millions of US $)
2021-06-30 $-6
2021-03-31 $-6
2020-12-31 $-5
2020-09-30 $-4
2020-06-30 $-5
2020-03-31 $-6
2019-12-31 $-4
2019-09-30 $-4
2019-06-30 $-4
2019-03-31 $-4
2018-12-31 $-4
2018-09-30 $-4
2018-06-30 $-5
2018-03-31 $-5
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-3
2017-03-31 $-3
2016-12-31 $-3
2016-09-30 $-3
2016-06-30 $-3
2016-03-31 $-2
2015-12-31 $-3
2015-09-30 $-3
2015-06-30 $-2
2015-03-31 $-2
2014-12-31 $-1
2014-09-30 $-6
2014-06-30 $1
2014-03-31 $-2
2013-12-31 $-1
2013-09-30 $-1
2013-06-30 $-1
2013-03-31 $-1
2012-12-31 $-1
2012-09-30 $-1
2012-06-30 $-1
2012-03-31 $-1
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.182B $0.000B
Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.527B 7.92
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.184B 20.63
Biohaven Pharmaceutical Holding (BHVN) United States $8.967B 0.00
Emergent Biosolutions (EBS) United States $2.590B 6.25
Arcus Biosciences (RCUS) United States $2.362B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.929B 0.00
Myovant Sciences (MYOV) United Kingdom $1.832B 0.00
Zymeworks (ZYME) Canada $1.055B 0.00
Ambrx Biopharma (AMAM) United States $0.463B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.67